Global Biotech Stocks

ECS Botanics Holdings

Market Cap: AU$8.4m

Engages in the cultivation, manufacture, and sale of medicinal cannabis products in Australia and internationally.

Mainz Biomed

Market Cap: US$5.5m

Develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe.

Incanthera

Market Cap: UK£4.1m

A dermatology and oncology therapeutics company, focuses on the dermatological formulation and delivery technologies for various indications.

Pasithea Therapeutics

Market Cap: US$5.5m

A clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers.

CordovaCann

Market Cap: US$5.5m

Engages in identifying, funding, developing, and managing operations in the cannabis value chain business.

Mystic Holdings

Market Cap: US$5.5m

Through its subsidiaries, engages in the cultivation, production, and wholesale of medical and recreational cannabis in Nevada, the United States.

ANG Lifesciences India

Market Cap: ₹460.7m

Engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally.

Rua Bioscience

Market Cap: NZ$8.8m

Engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally.

Xenetic Biosciences

Market Cap: US$5.0m

A biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.

Aditxt

Market Cap: US$4.9m

A commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health.

Onconetix

Market Cap: US$4.9m

A biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology in the United States, European Union, and Non-European Union.

Quest PharmaTech

Market Cap: CA$6.8m

A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.

CNS Pharmaceuticals

Market Cap: US$4.8m

A clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors.

ExpreS2ion Biotech Holding

Market Cap: SEK 45.2m

A biotechnology company, develops vaccines and biologics products to address critical unmet medical needs in the Nordics and internationally.

Stem Cells Spin

Market Cap: zł17.4m

Operates as a biotechnology company in Poland.

Purple Biotech

Market Cap: ₪15.9m

A clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.

Shuttle Pharmaceuticals Holdings

Market Cap: US$4.7m

A clinical stage pharmaceutical company, develops novel therapies to cure cancers.

Epsilon Healthcare

Market Cap: AU$7.2m

Operates as a healthcare and pharmaceuticals company primarily in Australia.

Spruce Biosciences

Market Cap: US$4.7m

A biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.

Revive Therapeutics

Market Cap: CA$6.5m

A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.

Jaguar Health

Market Cap: US$4.7m

A commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress.

Medicamen Organics

Market Cap: ₹410.1m

Engages in the developing, manufacturing, and distribution of a range of pharmaceutical dosage in India and internationally.

Roquefort Therapeutics

Market Cap: UK£3.5m

A material biotech company, engages in the development of medicines for the treatment of cancer.

Delivra Health Brands

Market Cap: CA$6.4m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

Reflect Scientific

Market Cap: US$4.5m

Through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide.

BSF Enterprise

Market Cap: UK£3.3m

Develops and commercializes cutting-edge tissue-engineered solutions.

InMed Pharmaceuticals

Market Cap: US$4.4m

A clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.

bioAffinity Technologies

Market Cap: US$4.2m

Engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.

Herbal Dispatch

Market Cap: CA$5.7m

Owns and operates cannabis e-commerce platforms in Canada and the United States.

Biodexa Pharmaceuticals

Market Cap: US$4.0m

A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.

Applied DNA Sciences

Market Cap: US$3.8m

A biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally.

Acrux

Market Cap: AU$5.7m

Develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.

Theriva Biologics

Market Cap: US$3.7m

A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.

Vineet Laboratories

Market Cap: ₹325.5m

Engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals in India.

FinCanna Capital

Market Cap: CA$5.0m

Does not have significant operations.

1933 Industries

Market Cap: CA$5.0m

Engages in the cultivation, extraction, and production of cannabis products in the United States.